EW EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
EW's ev/ebitda is right around its 10-year median of 30.2.
EV/EBITDA History
EW EV/EBITDA by year
Yearly range of EW’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 20.4 to 60.3, averaging 33.1.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 29.6 | 32.7 | 36.0 | 30.2 |
| 2025 | 20.4 | 24.2 | 34.0 | 34.0 |
| 2024 | 21.1 | 28.8 | 36.4 | 23.7 |
| 2023 | 22.0 | 26.6 | 33.6 | 27.3 |
| 2022 | 22.8 | 32.4 | 43.2 | 24.8 |
| 2021 | 35.3 | 45.6 | 60.3 | 43.6 |
| 2020 | 25.7 | 43.1 | 57.7 | 54.2 |
| 2019 | 36.1 | 47.3 | 54.3 | 38.3 |
| 2018 | 21.7 | 27.2 | 38.5 | 38.5 |
| 2017 | 21.3 | 24.7 | 27.5 | 24.7 |
| 2016 | 21.8 | 27.4 | 34.0 | 25.1 |
Get notified when EW EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is EW EV/EBITDA High or Low Right Now?
Edwards Lifesciences Corporation's EV/EBITDA is currently 30.2, which is around average relative to its 10-year historical range. The 10-year median EV/EBITDA for EW is approximately 30.2. See all EW valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.